Catherine Campana
Analyst, Goldman Sachs
Replay available
TD SYNNEX Corporation (NYSE: SNX) Q2 2025 earnings conference call, held 2025-06-24. Replay captured from the company's public earnings webcast.

Analyst, Goldman Sachs
Analyst, Morgan Stanley
Analyst, Bank of America
Analyst, UBS
Analyst, RBC Capital Markets
Analyst, J.P. Morgan
Analyst, Loop Capital Markets
or other statements about future events, including statements about our strategy, demand, plans and positioning, growth, cash flow, capital allocation, and stockholder return, as well as our financial expectations for future fiscal periods. Actual results may differ materially from those mentioned in these forward-looking statements as a result of risk and uncertainties discussed in today's earnings release. In the Form 8-K we filed today, in the risk factors section of our Form 10-K and other reports and filings with the SEC. We do not intend to update any forward-looking statements. Also, during this call, we will reference certain non-GAAP financial information. Reconciliations of GAAP to non-GAAP results are included in the earnings press release and the related Form 8-K available on our investor relations website, ir.tdsenex.com. This conference call is the property of TD Cinex and may not be recorded or rebroadcast without our permission. I will now turn the call over to Patrick. Patrick? Thank you, David. Good morning, everyone, and thank you for joining us today. I'm excited to report on our strong second quarter performance and provide an update on the impacts we are seeing from the macroeconomic uncertainties. Our Q2 results demonstrate the continued strength of the IT distribution and hyperscaler markets. Meanwhile, our strategy and the execution of our team are enabling us to grow ahead of market. In Q2, gross billings grew 12%. 11% in constant currency and non-GAAP deleted EPS exceeded the high end of our guidance with all regions and major technologies contributing. We believe the quarter benefited from some demand pull forward. Within TDC-NEXT, excluding HIVE, gross billings grew 11% year over year and operating margins expanded, resulting in strong op...